Arax Advisory Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-24
Closed -$2K 619
2019
Q3
$2K Hold
24
﹤0.01% 558
2019
Q2
$2K Buy
+24
New +$2.28K ﹤0.01% 562
2018
Q4
$16K Buy
252
+86
+52% +$6.35K 0.01% 400
2018
Q3
$15K Sell
166
-205
-55% -$18.1K 0.01% 440
2018
Q2
$29K Buy
371
+154
+71% +$12.8K 0.01% 271
2018
Q1
$19K Buy
217
+157
+262% +$15.1K 0.01% 287
2017
Q4
$6K Sell
60
-564
-90% -$63.6K ﹤0.01% 363
2017
Q3
$90K Sell
624
-109
-15% -$14.8K 0.04% 154
2017
Q2
$95K Buy
733
+207
+39% +$25.4K 0.05% 162
2017
Q1
$65K Buy
526
+287
+120% +$34.3K 0.03% 175
2016
Q4
$28K Buy
+239
New +$26.6K 0.01% 231

Other funds holding CELG

Arax Advisory Partners's CELG Position: Q4 2019 in Review

Arax Advisory Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 24 shares — an estimated $2K sold.

Arax Advisory Partners first reported a position in CELG in Q4 2016 and held it in 11 quarters. The position peaked at $95K in Q2 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Arax Advisory Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Arax Advisory Partners sold 24 Celgene Corp shares in Q4 2019, an estimated $2K.
  • Arax Advisory Partners first reported a position in Celgene Corp in Q4 2016 and held it in 11 quarters.
  • Arax Advisory Partners's Celgene Corp position peaked at $95K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Arax Advisory Partners's 13F filing for Q4 2019, filed 7 Feb 2020.